Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

20%

Ph phase_3

20%

Ph phase_4

20%

Ph phase_2

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

2(40.0%)

Phase 3Large-scale testing

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Other(2)

Detailed Status

Completed3

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (20.0%)

Phase 22 (40.0%)

Phase 31 (20.0%)

Phase 41 (20.0%)

Trials by Status

unknown240%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_4

Oncoxin® and Quality of Life in Cancer Patients

NCT03550482

completedphase_2

Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

NCT03577535

unknownphase_2

Clinical Trials (5)

Showing 5 of 5 trials

NCT03550482Phase 4

Oncoxin® and Quality of Life in Cancer Patients

Completed

NCT03577535Phase 2

Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

Completed

NCT01747642Phase 2

Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma

Unknown

NCT01392131Phase 1

Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)

Unknown

NCT00967681Phase 3

Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

Completed

All 5 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 5